In Brief: Antipsychotic Update
The Carlat Psychiatry Report, Volume 18, Number 1, January 2020
https://www.thecarlatreport.com/newsletter-issue/tcprv18n1/
From The Carlat Psychiatry Report, January 2020, Esketamine
Issue Links: Learning Objectives | Editorial Information
FDA Clears the Path for Magic Mushrooms. Psilocybin, the psychedelic compound in magic mushrooms, was fast-tracked by the FDA for major depression in November 2019.
You can't view details of this content, please login or buy subscription here